{"id":2095,"date":"2026-05-06T18:57:20","date_gmt":"2026-05-06T18:57:20","guid":{"rendered":"https:\/\/retina-eye.co.uk\/?p=2095"},"modified":"2026-06-03T13:22:32","modified_gmt":"2026-06-03T13:22:32","slug":"impact-of-diabetic-treatment-on-diabetic-retinopathy","status":"publish","type":"post","link":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/","title":{"rendered":"\u7cd6\u5c3f\u75c5\u6cbb\u7597\u5bf9\u7cd6\u5c3f\u75c5\u89c6\u7f51\u819c\u75c5\u53d8\u7684\u5f71\u54cd"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Key Takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy.<\/li>\n\n\n\n<li>Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications.<\/li>\n\n\n\n<li>GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy.<\/li>\n\n\n\n<li>Early detection, consistent follow-up, and combined systemic and ocular treatments lead to better long-term visual outcomes.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Diabetes is a chronic condition that affects millions of people worldwide and has far-reaching effects on various organs, including the eyes. One of the most serious complications is diabetic retinopathy, a progressive disease that damages the small blood vessels in the retina and can lead to vision loss if left untreated [1].<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Diabetic treatment directly impacts diabetic retinopathy by improving blood sugar control, reducing vascular damage, and slowing disease progression, although rapid changes in glucose levels may temporarily affect retinal status. Understanding how different treatment approaches influence retinal health is crucial for both patients and healthcare providers aiming to preserve vision.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Understanding Diabetic Retinopathy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Diabetic retinopathy develops as a result of prolonged exposure to high blood sugar levels, which weaken and damage the retinal microvasculature. Over time, these vessels may leak fluid, close off, or stimulate the growth of abnormal new vessels [2]. The condition progresses through several stages:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Non-proliferative stage:<\/strong> Early damage with microaneurysms and mild leakage<\/li>\n\n\n\n<li><strong>Moderate to severe stage:<\/strong> Increasing vessel blockage and retinal ischemia<\/li>\n\n\n\n<li><strong>Proliferative stage:<\/strong> Growth of fragile new blood vessels that can bleed<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Without proper intervention, diabetic retinopathy can lead to complications such as macular oedema, retinal detachment, and permanent vision loss.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Role of Glycemic Control<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Maintaining optimal blood glucose levels is the most important factor in preventing and managing diabetic retinopathy. Persistent hyperglycemia accelerates vascular damage and promotes inflammation within the retina [3]. Effective glycemic control helps to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reduce the risk of developing diabetic retinopathy<\/li>\n\n\n\n<li>Slow progression in existing cases<\/li>\n\n\n\n<li>Improve response to ocular treatments<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Clinical studies have shown that even modest improvements in blood sugar levels can significantly reduce complications. However, gradual control is recommended to avoid sudden shifts that may temporarily worsen diabetic retinopathy [4].<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Blood Pressure and Lipid Management<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Beyond glucose control, managing other systemic factors is equally important in reducing the burden of diabetic retinopathy.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Blood Pressure Control:<\/strong> Hypertension increases stress on already fragile retinal vessels. Lowering blood pressure helps reduce leakage and prevents further damage.<\/li>\n\n\n\n<li><strong>Lipid Control:<\/strong> Elevated cholesterol contributes to the formation of lipid deposits in the retina, worsening visual outcomes. Lipid-lowering therapies can help stabilize retinal health.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A comprehensive approach addressing these factors is essential for effective management of diabetic retinopathy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The Role of GLP-1 Receptor Agonists<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">GLP-1 (glucagon-like peptide-1) receptor agonists are a newer class of medications used in the treatment of type 2 diabetes. These drugs work by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying. Common GLP-1 medications include semaglutide, liraglutide, and dulaglutide. These agents provide multiple benefits:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Improved glycemic control<\/li>\n\n\n\n<li>Weight loss<\/li>\n\n\n\n<li>Cardiovascular protection<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">However, their relationship with diabetic retinopathy is complex. Some clinical trials have observed that rapid reductions in blood glucose\u2014particularly in patients with pre-existing disease\u2014may lead to a temporary worsening of diabetic retinopathy [5].<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is important to note that this effect is not specific to GLP-1 drugs but is associated with any rapid improvement in glycemic control. Therefore, patients initiating GLP-1 therapy should undergo baseline and follow-up eye examinations to monitor changes in diabetic retinopathy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Some studies have also shown progression of mild- moderate degrees of non proliferative diabetic retinopathy with use of GLP 1 drugs such as semaglutide . Further clinical trial such as the FOCUS study will hopefully provide further information of long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ocular Treatments and Their Interaction with Systemic Therapy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">While systemic diabetic treatment addresses the root causes, ocular therapies directly target retinal damage caused by diabetic retinopathy. Common interventions include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Anti-VEGF injections:<\/strong> Reduce abnormal vessel growth and fluid leakage [6]<\/li>\n\n\n\n<li><strong>Laser photocoagulation:<\/strong> Stabilizes retinal tissue by sealing leaking vessels<\/li>\n\n\n\n<li><strong>Corticosteroid injections:<\/strong> Decrease inflammation in selected cases<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">These treatments are most effective when combined with optimal systemic control. Without proper diabetes management, the benefits of ocular therapy for diabetic retinopathy may be limited.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Treatment Impact Comparison<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Treatment Type<\/strong><\/td><td><strong>Primary Effect<\/strong><\/td><td><strong>Impact on Diabetic Retinopathy<\/strong><\/td><\/tr><tr><td>Blood Sugar Control<\/td><td>Stabilizes glucose levels<\/td><td>Slows progression<\/td><\/tr><tr><td>Blood Pressure Management<\/td><td>Reduces vascular stress<\/td><td>Decreases complications<\/td><\/tr><tr><td>Lipid-Lowering Therapy<\/td><td>Improves cholesterol levels<\/td><td>Reduces retinal damage<\/td><\/tr><tr><td>GLP-1 Receptor Agonists<\/td><td>Enhances glycemic control<\/td><td>Requires monitoring for early changes<\/td><\/tr><tr><td>Ocular Interventions<\/td><td>Treats retinal damage directly<\/td><td>Improves or stabilizes vision<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Importance of Early Detection and Monitoring<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Regular eye examinations are critical for detecting diabetic retinopathy in its early stages. Because symptoms may not appear until the disease is advanced, routine screening is essential. Monitoring tools include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dilated eye examinations<\/li>\n\n\n\n<li>Optical coherence tomography (OCT)<\/li>\n\n\n\n<li>Fundus photography<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Early detection allows for timely intervention, improving the chances of preserving vision in patients with diabetic retinopathy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Long-Term Management and Patient Involvement<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Managing diabetes and its complications requires a long-term commitment. Patients play a crucial role in maintaining their eye health. Key components of long-term care include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Adherence to medications, including GLP-1 therapies if prescribed<\/li>\n\n\n\n<li>Regular monitoring of blood glucose, blood pressure, and cholesterol<\/li>\n\n\n\n<li>Maintaining a healthy lifestyle with balanced nutrition and exercise<\/li>\n\n\n\n<li>Attending scheduled medical and eye appointments<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Active patient participation enhances the effectiveness of treatment and reduces the risk of worsening diabetic retinopathy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Challenges in Managing Diabetic Retinopathy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Despite advancements in treatment, several challenges remain in managing diabetic retinopathy. These include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Limited access to specialized eye care in some regions<\/li>\n\n\n\n<li>Financial barriers to treatment<\/li>\n\n\n\n<li>Poor adherence to medication or follow-up schedules<\/li>\n\n\n\n<li>Lack of awareness about the importance of eye health<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Addressing these barriers through education, support, and healthcare access is essential for improving outcomes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Future Directions in Diabetic Care<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ongoing research continues to improve the management of diabetes and its complications. Advances in pharmacotherapy, including newer GLP-1 formulations, aim to provide better glycemic control with fewer side effects.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition, emerging therapies targeting inflammation and vascular dysfunction may further enhance the treatment of diabetic retinopathy. Technological innovations such as telemedicine and AI-assisted screening are also expanding access to early detection and care.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Diabetic treatment has a profound and direct impact on the development and progression of diabetic retinopathy. Effective management of blood glucose, blood pressure, and lipids forms the foundation of prevention, while medications such as GLP-1 receptor agonists offer additional systemic benefits.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">By combining systemic control with regular eye monitoring and timely interventions, patients can significantly reduce their risk of vision loss. A proactive, informed approach remains essential for successfully managing diabetic retinopathy and maintaining long-term visual health.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">References<\/h4>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Cheung, N., Mitchell, P., &amp; Wong, T. Y. (2010). Diabetic retinopathy. <em>The Lancet, 376<\/em>(9735), 124\u2013136. <a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3\">https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3<\/a><\/li>\n\n\n\n<li>Antonetti, D. A., Klein, R., &amp; Gardner, T. W. (2012). Diabetic retinopathy. <em>New England Journal of Medicine, 366<\/em>(13), 1227\u20131239.<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMra1005073\"> https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMra1005073<\/a><\/li>\n\n\n\n<li>Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. <em>New England Journal of Medicine, 329<\/em>(14), 977\u2013986.<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM199309303291401\"> https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM199309303291401<\/a><\/li>\n\n\n\n<li>UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment. <em>The Lancet, 352<\/em>(9131), 837\u2013853. <a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(98)07019-6\">https:\/\/doi.org\/10.1016\/S0140-6736(98)07019-6<\/a><\/li>\n\n\n\n<li>Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., J\u00f3dar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., Woo, V., &amp; Hansen, O. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. <em>New England Journal of Medicine, 375<\/em>(19), 1834\u20131844.<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1607141\"> https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1607141<\/a><\/li>\n\n\n\n<li>Diabetic Retinopathy Clinical Research Network. (2015). Randomized clinical trial evaluating intravitreal aflibercept, bevacizumab, and ranibizumab for diabetic macular edema. <em>New England Journal of Medicine, 372<\/em>(13), 1193\u20131203.<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1414264\"> https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1414264<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Diabetes is a chronic condition that affects millions of people worldwide and has far-reaching effects on various organs, including the eyes. One of the most serious complications is diabetic retinopathy, a progressive disease that damages the small blood vessels in the retina and can lead to vision loss if left untreated [1]. Diabetic [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2324,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-2095","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diabetic-retinopathy"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"zh_CN\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Retina Eye - Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye\" \/>\n\t\t<meta property=\"og:description\" content=\"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-06T18:57:20+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-03T13:22:32+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#blogposting\",\"name\":\"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye\",\"headline\":\"Impact of Diabetic Treatment on Diabetic Retinopathy\",\"author\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Impact-of-Diabetic-Treatment-on-Diabetic-Retinopathy-1.jpg\",\"width\":1000,\"height\":621},\"datePublished\":\"2026-05-06T18:57:20+00:00\",\"dateModified\":\"2026-06-03T13:22:32+00:00\",\"inLanguage\":\"zh-CN\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#webpage\"},\"articleSection\":\"Diabetic Retinopathy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/diabetic-retinopathy\\\/#listItem\",\"name\":\"Diabetic Retinopathy\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/diabetic-retinopathy\\\/#listItem\",\"position\":2,\"name\":\"Diabetic Retinopathy\",\"item\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/diabetic-retinopathy\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#listItem\",\"name\":\"Impact of Diabetic Treatment on Diabetic Retinopathy\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#listItem\",\"position\":3,\"name\":\"Impact of Diabetic Treatment on Diabetic Retinopathy\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/diabetic-retinopathy\\\/#listItem\",\"name\":\"Diabetic Retinopathy\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#organization\",\"name\":\"Retina Eye\",\"description\":\"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Retina-Eye-Uk-Logo-final.png\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#organizationLogo\",\"width\":498,\"height\":355},\"image\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/litespeed\\\/avatar\\\/4670ef77034ec9acb289c5943cd6a2f6.jpg?ver=1785601329\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#webpage\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/\",\"name\":\"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye\",\"description\":\"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular\",\"inLanguage\":\"zh-CN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Impact-of-Diabetic-Treatment-on-Diabetic-Retinopathy-1.jpg\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#mainImage\",\"width\":1000,\"height\":621},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/impact-of-diabetic-treatment-on-diabetic-retinopathy\\\/#mainImage\"},\"datePublished\":\"2026-05-06T18:57:20+00:00\",\"dateModified\":\"2026-06-03T13:22:32+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#website\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/\",\"name\":\"Retina Eye\",\"description\":\"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon\",\"inLanguage\":\"zh-CN\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye","description":"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular","canonical_url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#blogposting","name":"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye","headline":"Impact of Diabetic Treatment on Diabetic Retinopathy","author":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author"},"publisher":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/uploads\/2026\/05\/Impact-of-Diabetic-Treatment-on-Diabetic-Retinopathy-1.jpg","width":1000,"height":621},"datePublished":"2026-05-06T18:57:20+00:00","dateModified":"2026-06-03T13:22:32+00:00","inLanguage":"zh-CN","mainEntityOfPage":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#webpage"},"isPartOf":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#webpage"},"articleSection":"Diabetic Retinopathy"},{"@type":"BreadcrumbList","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh#listItem","position":1,"name":"Home","item":"https:\/\/www.retina-eye.co.uk\/zh","nextItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/diabetic-retinopathy\/#listItem","name":"Diabetic Retinopathy"}},{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/diabetic-retinopathy\/#listItem","position":2,"name":"Diabetic Retinopathy","item":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/diabetic-retinopathy\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#listItem","name":"Impact of Diabetic Treatment on Diabetic Retinopathy"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#listItem","position":3,"name":"Impact of Diabetic Treatment on Diabetic Retinopathy","previousItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/diabetic-retinopathy\/#listItem","name":"Diabetic Retinopathy"}}]},{"@type":"Organization","@id":"https:\/\/www.retina-eye.co.uk\/zh\/#organization","name":"Retina Eye","description":"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon","url":"https:\/\/www.retina-eye.co.uk\/zh\/","logo":{"@type":"ImageObject","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/uploads\/2026\/07\/Retina-Eye-Uk-Logo-final.png","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#organizationLogo","width":498,"height":355},"image":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author","url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#authorImage","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/litespeed\/avatar\/4670ef77034ec9acb289c5943cd6a2f6.jpg?ver=1785601329","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#webpage","url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/","name":"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye","description":"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular","inLanguage":"zh-CN","isPartOf":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/#website"},"breadcrumb":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#breadcrumblist"},"author":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author"},"creator":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/uploads\/2026\/05\/Impact-of-Diabetic-Treatment-on-Diabetic-Retinopathy-1.jpg","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#mainImage","width":1000,"height":621},"primaryImageOfPage":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/#mainImage"},"datePublished":"2026-05-06T18:57:20+00:00","dateModified":"2026-06-03T13:22:32+00:00"},{"@type":"WebSite","@id":"https:\/\/www.retina-eye.co.uk\/zh\/#website","url":"https:\/\/www.retina-eye.co.uk\/zh\/","name":"Retina Eye","description":"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon","inLanguage":"zh-CN","publisher":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/#organization"}}]},"og:locale":"zh_CN","og:site_name":"Retina Eye - Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon","og:type":"article","og:title":"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye","og:description":"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular","og:url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/","og:image":"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png","og:image:secure_url":"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png","article:published_time":"2026-05-06T18:57:20+00:00","article:modified_time":"2026-06-03T13:22:32+00:00","twitter:card":"summary_large_image","twitter:title":"Impact of Diabetic Treatment on Diabetic Retinopathy - Retina Eye","twitter:description":"Key Takeaways Effective diabetes management is essential for preventing and slowing the progression of diabetic retinopathy. Tight control of blood glucose, blood pressure, and lipids significantly reduces the risk of complications. GLP-1 receptor agonists improve systemic outcomes but require careful monitoring for changes in diabetic retinopathy. Early detection, consistent follow-up, and combined systemic and ocular","twitter:image":"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png"},"aioseo_meta_data":{"post_id":"2095","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-05-06 18:57:23","updated":"2026-06-03 13:56:53","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.retina-eye.co.uk\/zh\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/diabetic-retinopathy\/\" title=\"Diabetic Retinopathy\">Diabetic Retinopathy<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tImpact of Diabetic Treatment on Diabetic Retinopathy\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.retina-eye.co.uk\/zh"},{"label":"Diabetic Retinopathy","link":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/diabetic-retinopathy\/"},{"label":"Impact of Diabetic Treatment on Diabetic Retinopathy","link":"https:\/\/www.retina-eye.co.uk\/zh\/post\/impact-of-diabetic-treatment-on-diabetic-retinopathy\/"}],"_links":{"self":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts\/2095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/comments?post=2095"}],"version-history":[{"count":1,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts\/2095\/revisions"}],"predecessor-version":[{"id":2097,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts\/2095\/revisions\/2097"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/media\/2324"}],"wp:attachment":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/media?parent=2095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/categories?post=2095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/tags?post=2095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}